Lori J. Braender

CIK: 0001752955

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AQST

Aquestive Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

AQST
Aquestive Therapeutics, Inc.
May 7, 2026
Tax Payment(F)
Direct
135.7K shares at avg. $4.23$574K
AQST
Aquestive Therapeutics, Inc.
May 5, 2026
Tax Payment(F)
Direct
76.1K shares at avg. $4.18$318K
AQST
Aquestive Therapeutics, Inc.
Mar 10, 2026
Sale(S)
Direct
40.1K shares at avg. $4.17$167K
AQST
Aquestive Therapeutics, Inc.
Mar 9, 2026
Award(A)
Direct
80K shares-
AQST
Aquestive Therapeutics, Inc.
Mar 9, 2025
Tax Payment(F)
Direct
10.7K shares at avg. $2.65$28K
AQST
Aquestive Therapeutics, Inc.
Mar 7, 2025
Award(A)
Performance Stock Units
Direct
82.5K shares-
AQST
Aquestive Therapeutics, Inc.
Mar 7, 2025
Tax Payment(F)
Direct
9.6K shares at avg. $2.65$25K
AQST
Aquestive Therapeutics, Inc.
Mar 7, 2025
Award(A)
Direct
110K shares-

		Type	Shares	Price		Ownership
May 7, 2026	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	135,690	$4.23	$573,969	Direct
May 5, 2026	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	76,147	$4.18	$318,294	Direct
Mar 10, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	40,102	$4.17	$167,346	Direct
Mar 9, 2026	AQST Aquestive Therapeutics, Inc.	Award(A)	80,000	-	$0	Direct
Mar 9, 2025	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	10,658	$2.65	$28,244	Direct
Mar 7, 2025	AQST Aquestive Therapeutics, Inc.	Award(A) Performance Stock Units	82,500	-	-	Direct
Mar 7, 2025	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	9,592	$2.65	$25,419	Direct
Mar 7, 2025	AQST Aquestive Therapeutics, Inc.	Award(A)	110,000	-	-	Direct

1-8 of 8 transactions

About BRAENDER LORI J

BRAENDER LORI J (SEC CIK 0001752955) files insider reports with the SEC as Corporate Secretary of Aquestive Therapeutics, Inc. (AQST).

Signal8 holds 5 ownership filings by BRAENDER LORI J, all Form 4s, filed between Mar 11, 2025 and May 11, 2026. Those filings report 8 transactions, from Mar 7, 2025 to May 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BRAENDER LORI J's filings is in WARREN, NJ.

Recent filings by BRAENDER LORI J

May 7, 2026: Tax withholding of AQST shares (Form 4, code F).
May 5, 2026: Tax withholding of AQST shares (Form 4, code F).
Mar 10, 2026: Open-market sale of AQST shares (Form 4, code S).
Mar 9, 2026: Grant or award of AQST shares (Form 4, code A).
Mar 9, 2025: Tax withholding of AQST shares (Form 4, code F).

Other insiders filing for Aquestive Therapeutics, Inc. (AQST)

Cochran John, Director
Barber Daniel, President and CEO
Daly Richard J, Director
Korczynski Sherry, Chief Commercial Officer
Boyd Peter E., Chief People Officer
Jung Cassie, Chief Operating Officer

How to read Form 4 transaction codes